Singular Genomics Announces Closing of Acquisition by Deerfield Management

Benzinga
2025.02.21 15:05
portai
I'm PortAI, I can summarize articles.

Singular Genomics Systems, Inc. has completed its acquisition by Deerfield Management Company, with the transaction closing on February 21, 2025. Deerfield acquired all outstanding shares of Singular Genomics for $20.00 per share. Following the acquisition, Singular Genomics will operate as a private company, and its common stock has been suspended from trading on Nasdaq. Josh Stahl has been appointed as the new CEO, with Drew Spaventa continuing as a board member and special advisor. The acquisition aims to provide Singular Genomics with greater flexibility to advance its business strategy.

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.